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Evidence has accumulated that hydrocar-
bons (HCs) in fuels and solvents are repro-
ductive toxicants. For example, reductions
in female fertility have been identified in
occupational groups exposed to organic sol-
vents containing benzene (Cho et al. 2000),
toluene (Plenge-Bönig and Karmaus 1999),
and mixtures of solvents (Sallmén et al.
1995; Smith et al. 1997a). Fuels, solvents,
and their constituent chemicals are ubiqui-
tous exposures. Contact may occur during
routine home or workplace activities, such
as refueling automobiles, mowing lawns, or
painting, reﬁnishing, or degreasing. Among
those occupational populations at risk of
high-level exposures to fuels and solvents
were farmers, mechanics, maintenance
workers, printers, petroleum refinery work-
ers, metal cleaners, painters, and aircraft
maintenance personnel.
Approximately 116,000 women work for
the U.S. Air Force (USAF) as ofﬁcers, enlisted
personnel, and civilians (Air Force Personnel
Center, Randolph AFB, 2000). Women have
held jobs in the USAF that involve handling
fuel, maintaining jets and ground vehicles,
and working on the flight line. These jobs
potentially expose women to fuels such as JP-
8 (jet fuel) and diesel; a variety of solvents,
including toluene and xylene; and products of
fuel combustion. Furthermore, gender differ-
ences in exposure, toxicokinetics, and physio-
logic responses may affect susceptibility to the
potential effects of fuel and solvent exposure.
Pharmacokinetic modeling revealed that
women metabolize 23–26% more benzene
than do men under the same exposure condi-
tions and therefore may have different
responses to exposure than do men (Brown et
al. 1998). Historically, over 3 billion gallons
of jet fuel have been issued annually to the
U.S. Department of Defense (Directorate of
Resources Management 1999). The principal
jet fuel used by the USAF, JP-8, is a mixture
of petroleum distillates composed primarily of
aliphatic and aromatic HCs in approximately
a 6:1 ratio (Pleil et al. 2000; Smith et al.
1997b). Among the constituent HCs com-
mon to both JP-8 and other, more commonly
used solvents are aliphatic HCs such as
hexane and aromatic HCs such as toluene
and xylenes (ATSDR 1993; Ikeda 1992;
Lemasters et al. 1997). Fuel and solvents may
be encountered separately or as mixtures dur-
ing job activities such as aircraft maintenance.
The purpose of this study was to assess
the potential effects of fuel and solvent expo-
sure on menstrual cycle function. We moni-
tored speciﬁc endocrine end points that are
predictive of conceptive menstrual cycles
(Baird et al. 1999) as subclinical markers of
female reproductive dysfunction to identify
early, subtle reproductive effects of low-dose
exposures to solvents and fuels.
Materials and Methods
Study population. The study population con-
sisted of female USAF employees. We
obtained approval from the University of
Cincinnati and the USAF prior to initiation
of recruitment. We recruited potential partic-
ipants for initial interviews by phone and in
person at 10 USAF bases. Eligibility criteria
included age between 18 and 42 years and
requirements that the subject had not used
hormonal medications, oral contraceptives,
or hormone replacement for 3 months; had
not used an intrauterine device during the
past 3 months; had no surgery, other than
tubal ligation, on reproductive tissues; had
not been pregnant or breast-feeding for 3
months; had not been diagnosed with any of
the following: chronic pelvic inflammatory
disease; endometriosis; vaginal, cervical,
uterine, or ovarian cancer; systemic lupus
erythematosus; hypopituitarism; Cushing’s
syndrome; sarcoidosis; pituitary tumor; acute
hepatitis; HIV or AIDS; cirrhosis of the liver;
hypothyroidism; hyperthyroidism; multiple
sclerosis; tuberculosis; or diabetes. We tar-
geted nonsmokers; however, we also included
a small subset of smokers (n = 8). Of the civil-
ian and active military women employed at
the 10 USAF bases who were contacted, 335
were preliminarily eligible during recruitment
screening. Of these women, 51% (n = 170)
provided informed consent and participated
by maintaining daily diaries and collecting
daily urine samples, and were confirmed as
eligible during the baseline interview.
Initial participant interview and diary
collection. During the initial interview, we
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Hydrocarbons (HCs) found in fuels and solvents are ubiquitous in the environment, yet we know
little about their effects on the endocrine system. The objective of this study was to assess the
potential reproductive endocrine effects of low-dose HCs encountered by female U.S. Air Force
personnel with fuel (primarily JP-8 jet fuel) and solvent exposures (n = 63). We estimated the
internal dose of HCs in fuels and solvents by measuring their levels in exhaled breath, including
the sum of aliphatic HCs (C6H14–C16H34) and the sum of aromatic HCs (benzene, ethylbenzene,
toluene, and m,p,o-xylenes). Adverse outcome measures included urinary endocrine markers that
have been associated with nonconceptive (vs. conceptive) menstrual cycles in ovulatory women:
lower preovulatory luteinizing hormone (LH) and mid-luteal phase pregnanediol 3-glucuronide
(Pd3G) and estrone 3-glucuronide, and higher follicle phase Pd3G. We also obtained reproduc-
tive and exposure information from baseline questionnaires and daily diaries. Toluene was the
most frequently found analyte in the breath, with values up to 52.0 ppb, and benzene breath lev-
els were up to 97.5 ppb. Regression analysis revealed that preovulatory LH levels were signifi-
cantly lower (p = 0.007) among women whose total aliphatic HC levels were above the median.
The relationship between elevated aliphatic HC exposure and lowered preovulatory LH levels in
the present study suggests that compounds in fuels and some solvents may act as reproductive
endocrine disruptors. Conﬁrmation of these ﬁndings is needed, not only to determine if fuel and
solvent exposure may impact other LH-dependent physiologic functions but also to examine
effects of fuels and solvents on conception. Key words: epidemiology, estrogen, fuel, hydrocarbon,
luteinizing hormone, military, progesterone, reproduction, solvent. Environ Health Perspect
110:805–811 (2002). [Online 25 June 2002]
http://ehpnet1.niehs.nih.gov/docs/2002/110p805-811reutman/abstract.htmlexplained the study procedures, eligibility cri-
teria, and the voluntary nature of participation
to the potential participants and we obtained
informed consent. Next, we administered the
baseline questionnaire to collect information
about their work, socioeconomic status, preg-
nancy, lifestyle, major life events (Horowitz et
al., 1977), and reproductive and menstrual
histories. Results of the menstrual history are
reported elsewhere (Gordley et al. 2000). We
provided instructions for collecting daily urine
samples and for completing daily diaries start-
ing the day after the initial interview. We also
measured weight and height.
We asked participants to immediately
begin maintaining their diaries daily and to
continue through the end of their second
postinterview menstrual period. The diary
requested menstrual, psychosocial, lifestyle,
work, chemical and physical exposures, and
sample collection information. We measured
job strain within the diaries using an abbre-
viated adaptation of the Job Content
Questionnaire developed by Karasek et al.
(1998). Participants mailed their diaries to
investigators upon completion.
Initial interview and daily diary informa-
tion abstracted to construct potential covari-
ates for preliminary analyses included age,
income group, marital status, education, race,
body weight, body mass index (BMI = weight
in kilograms ÷ height in square meters), alco-
holic beverage consumption, coffee and caf-
feine consumption, cigarettes smoked,
second-hand smoke exposure, episodes of ill-
ness and/or fever > 101°F, major life events,
job strain, hours worked, shifts worked, miles
run and walked, hours slept, physical activity
at home and work, exposure to cold tempera-
tures, and fuel and solvent exposure.
Endocrine data analyses. We collected
ﬁrst morning urine samples daily concurrent
to maintaining the diaries. Participants
stored the samples in home freezers; samples
contained 7% glycerol to prevent loss of
hormonal activity (Kesner et al. 1995).
Participants shipped frozen samples with
freezer packs to the National Institute for
Occupational Safety and Health (NIOSH)
laboratory by next-day courier. We stored
samples in the laboratory at –80°C until
assayed.
We ascertained menstrual periods from
the participants’ daily records of vaginal
bleeding based on a modiﬁcation of a previ-
ously described menstrual algorithm
(Hornsby 1991). The first day of the men-
strual cycle was the first of 2 consecutive
days of bleeding, only one of which could be
spotting. We counted 1–2 day interruptions
in bleeding (nonbleeding or spotting) that
occurred after day 2 of the period together
with bleeding days as part of the menses.
Menses were preceded and followed by 3 or
more consecutive days of nonbleeding or
spotting. We contacted participants with
missing diary menstrual bleeding entries
immediately regarding menses dates and
accepted reported menses dates up to 14
days retrospectively.
We used urinary endocrine measure-
ments and menses dates to derive the four
key endocrine end points using established
algorithms (Baird et al. 1999; Baird 1999).
Baird et al. (1999) reported that nonconcep-
tion during ovulatory cycles is associated with
elevated levels of follicular pregnanediol 3-
glucuronide (Pd3G) and reduced levels of
preovulatory luteinizing hormone (LH),
midluteal Pd3G, and possibly midluteal
estrone 3-glucuronide (E13G). Therefore, we
selected these end points a priori for analysis.
We assayed the major urinary metabolites
of estradiol and progesterone (i.e., E13G and
Pd3G) using competitive, double-antibody
time-resolved ﬂuoroimmunoassays (Kesner et
al. 1994b). We assayed urinary LH using a
commercial noncompetitive, two-site, time-
resolved immunoﬂuorometric assay (Kesner
et al. 1998, 1994a). Detailed characteristics
of these assays, including speciﬁcity, sensitiv-
ity, and precision, are described in their
respective references (Jaffe 1886; Kesner et al.
1994a, 1994b, 1998). We measured creati-
nine spectrophotometrically (Jaffe 1886) and
divided each urinary endocrine value by the
creatinine concentration to adjust for urine
dilution. We measured all samples for each
participant in the same assay. Intra-assay and
interassay coefﬁcients of variation for urinary
endocrine measurements were, respectively,
6.2% and 4.6% for LH, 15.4% and 10.1%
for E13G, 11.6% and 8.4% for Pd3G, and
0.97% and 3.4% for creatinine.
Internal dose exposure measures. We pre-
viously demonstrated that relatively low
internal doses of aromatic HCs in solvents
could be measured with greater sensitivity in
breath than in blood or urine (Lemasters et
al. 1999a). Therefore, we estimated internal
doses of aliphatic and aromatic HCs from
solvents and fuels in mixed-exhaled breath
samples collected from 63 participants. To
estimate analyte levels in the vessel-rich tis-
sue compartment, we collected a breath sam-
ple during the initial interview, 1.4 hr (SD =
2.2), on average, after participants left the
work site (Pellizzari et al. 1992) on the sec-
ond to fifth consecutive workday. For one
additional participant with no workday sam-
ple, we substituted a Monday (ﬁrst workday)
sample as a proxy measurement for this
analysis (total n = 63). We collected breath
samples through desiccant filters into
Tedlar bags (SKC Inc., Eighty Four, PA)
and then suctioned them into sorbent char-
coal tubes 1.5 hr (SD = 1.4), on average,
after collection.
In the laboratory, we concentrated breath
sample analytes by thermal desorption of the
sorbent tube contents onto the charcoal bed
of a Tekmar 3000 Purge and Trap (Tekmar-
Dohrmann, Mason, OH). We then flash-
heated the collected analytes to 225°C and
released to the heated nickel transfer line
under a constant back-pressure. We directly
connected the transfer line to the column
(DB-VRX, J&W Scientific, Folsom, CA)
with a zero dead volume union. We analyzed
the material with a Hewlett-Packard Model
5890 Series 2 gas chromatograph (Hewlett-
Packard, Wilmington, DE), equipped with a
flame ionization detector optimized for
detection of aromatic HCs, including ben-
zene, toluene, ethylbenzene, and m,p,o-
xylenes (BTEX). We performed quantitation
using a Hewlett-Packard Model 3396
Integrator and an EZ Chrom data system
(Scientiﬁc Software Inc., Pleasanton, CA).
We analyzed the samples in two batches
and quantified aliphatic C6H14–C16H34
(C6–C16) and aromatic (BTEX) HC levels as
area under the curve (AUC) for all 63 sam-
ples. We calculated sample concentrations
for AUC corresponding to 0.5 ppb,
although any individual sample had a 1%
statistical chance that background could
have been at the 1 ppb level. We derived
conversion factors for transforming the EZ
Chrom output from AUC to parts per bil-
lion of each BTEX analyte from calibration
samples for all study samples (n = 63). These
conversion factors demonstrated adequate
linearity for the aromatic analytes; goodness
of ﬁt ranged from an r2 of 0.88–0.98 based
on 10, 25, and 50 ppb calibration samples.
We examined the total BTEX exposure vari-
able as a continuous parts per billion variable
and as a dichotomous variable above and
below the median parts per billion value in
statistical analyses. After publication of a
report describing JP-8 volatile fraction “ﬁn-
gerprint compounds” (Pleil et al. 2000), we
began deriving parts per billion conversion
factors for aliphatic HCs and obtained parts
per billion values for a subset of study sam-
ples (n = 22). We developed a standard gas
in the laboratory to create conversion factors
for the aliphatic HCs; goodness of fit was
adequate (r2, 0.87–0.99 at 10, 25, and 50
ppb) for all analytes except dodecane (C12;
r2 = 0.10) and tetradecane (C14; r2 = 0.55).
Therefore, we converted aliphatic HC levels
(except C12 and C14) to parts per billion for
the second analysis batch of 22 samples. We
used only AUC measurements, not parts per
billion, in the statistical analysis of aliphatic
HCs for the 63 breath samples; we used the
aliphatic HC parts per billion levels only to
present range of exposure. We dichotomized
the total AUC for aliphatic HCs for each of
the two analysis batches (above or below the
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bined the two batches into a single dichoto-
mous aliphatic HC variable. Because
C6–C16 measurements were only available in
parts per billion units for a convenience sam-
ple of 22 participants, we did not explore
analysis with a combined breath exposure
variable (aliphatic HCs + BTEX). 
For quality control, we collected dupli-
cate breath samples in immediate succession
from 13 participants. We analyzed these sam-
ples and compared the duplicate measure-
ments. Intra- and interparticipant sample
coefficients of variation for exhaled breath
measurements in parts per billion were,
respectively, 3.6% and 0.0% for benzene,
1.8% and 0.8% for toluene, 5.1% and 0.0%
for ethylbenzene, 3.5% and 0.0% for
m,p-xylene, and 1.2% and 1.0% for o-xylene.
We assigned the duplicate, end-of-shift
breath sample levels from the 13 participants
to the same aliphatic HC and BTEX expo-
sure groups (high/low) approximately 70%
of the time, indicating relatively high compa-
rability among samples.
Statistical analysis. We conducted statis-
tical analyses of the potential relationship
between endocrine outcomes (preovulatory
LH, follicular Pd3G, midluteal Pd3G, and
midluteal E13G) and exposure variables on
two groups of participants: a) the 100 partic-
ipants with endocrine and recorded diary
data and b) for 63 of the 100 participants
with breath analysis data. For the bivariate
analysis of data from the women who
reported diary and baseline questionnaire
information (n = 100), we deﬁned exposure
using three reported exposure variables: a)
mean weekly hours reported as smelling or
having skin contact with fuels, b) mean
weekly hours reported as smelling or having
skin contact with solvents, and c) job cate-
gory (exposed vs. nonexposed) based on self-
report during the initial interview and review
of job titles, job codes, and descriptions by
USAF industrial hygiene personnel.
Variables used to characterize the internal
dose of HCs measured in the 63 breath sam-
ples were aliphatic C6–C16 (AUC) and
BTEX (parts per billion), each dichotomized
above and below their respective medians.
Square root transformation optimally
transformed the hormonal outcomes. The
variable selection strategy for regression
analysis involved examining bivariate associ-
ations between each of the four endocrine
end points (transformed and nontrans-
formed) and other potential covariates. We
assessed covariates that approached signifi-
cance (p ≤ 0.15) with at least one endocrine
level in unadjusted analysis bivariately as
potential confounders with fuel and BTEX
exposure variables. We retained those
approaching marginal signiﬁcance (p < 0.15)
with exposure variables for regression models
in subsequent analyses. Potential interactions
between breath exposure variables and alco-
holic beverages, and breath exposure vari-
ables and race did not approach signiﬁcance.
When intercorrelation between candidate
covariates was present, or when two or more
covariates represented similar constructs, we
used the variable with the most significant
association with the outcome(s). 
Covariates retained for regression models
containing reported hours of fuel or solvent
exposure included: age at interview (years),
BMI, race (white, nonwhite), alcoholic bever-
ages (number of drinks per day per kilogram
body weight), coffee consumption (estimated
mean milligrams of caffeine per day from cof-
fee), caffeine consumption (mean milligrams
total caffeine estimated from mean ounces of
coffee, tea, and soda recorded per day in
diary), running (mean miles run per day),
sleep (mean hours per day), any episodes of
illness and/or fever > 101°F (yes/no), maxi-
mum weekly job strain score (high vs. low),
and currently smoking cigarettes (yes/no). We
conducted separate regression analyses for
each reported exposure variable, and we
forced each exposure variable to remain in the
ﬁnal model. We conducted multiple regres-
sion analysis of each endocrine outcome sepa-
rately using backward stepwise elimination of
covariates, with signiﬁcant (p ≤ 0.05) covari-
ates retained in the ﬁnal models.
Covariates retained for regression models
containing breath analyte exposure variables
dichotomized about the median for aliphatic
(C6–C16) and BTEX included illness and/or
fever > 101°F, alcoholic beverages, maxi-
mum job strain, race group, and age. We
conducted multiple regression analysis of
each endocrine outcome as described above,
with both breath exposure variables forced to
remain in the regression models.
Results
Of the 170 women who completed the base-
line questionnaire, 100 participants provided
completed daily diaries and urine samples.
Fifty-three women did not return either
daily diaries and/or urine samples, and 13
women returned samples that were inade-
quate to evaluate the four key endocrine end
points. We excluded four participants retro-
spectively because of pregnancies (two), oral
contraceptive use (one), and symptomatic
endometriosis (one) that were reportedly
present during sample collection. Breath
samples to yield exposure data were also
available for 63 of these 100 compliant par-
ticipants. Compensation for time and incon-
venience was $50 for daily diaries, $25 for
urine samples, and $25 for breath samples.
Demographic and reproductive charac-
teristics. Table 1 describes demographic
and reproductive history characteristics for
the 100 eligible participants who provided
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Table 1. Demographic and reproductive characteristics of participants with endocrine data (n = 100) and
with endocrine and breath data (n = 63/100) by aliphatic HC group.
Endocrine and breath data (n = 63)
Endocrine data Low aliphatic High aliphatic Combined
Participant characteristic (n = 100) (n = 31)a (n = 32)a (n = 63)
Mean age at interview (years) 30.9 ± 6.2 30.5 ± 5.7 31.7 ± 5.5 31.1 ± 5.6
(18.0–41.0) (20.0–39.0) (20.0–40.0) (20.0–40.0)
Mean age at menarche (years) 12.7 ± 1.5 12.8 ± 1.6 12.8 ± 1.5 12.8 ± 1.5
(9.0–17.0) (10.0–17.0) (9.0–16.0) (9.0–17.0)
Race (%)
White 64.0 80.7 75.0 77.8
African American 30.0 16.1 21.9 19.0
Hispanic 4.0 0.0 3.1 1.6
Other 2.0 3.2 0.0 1.6
Education (%)
High school and/or technical training 20.0 19.4 18.8 19.1
Some college or associates degree 61.0 64.5 59.4 61.9
Four year degree or more 19.0 16.1 21.9 19.1
Family income (%)b
< $15,000 9.1 12.9 0.0 6.4
$15,000 < $30,000 32.3 35.5 34.4 34.9
≥ $30,000 58.6 51.6 65.6 58.7
Military personnel status (%) 84.0 87.1 71.9 79.4
Marital status (%)b
Currently married or partner 61.6 54.8 68.8 61.9
Widowed, divorced, or separated 16.2 12.9 15.3 14.3
Never married 23.2 32.3 15.6 23.8
One or more children (%) 63.0 64.5 75.0 69.8
Irregular menses past 3 months (%) 11.0 16.1 6.3 11.1
Dysmenorrhea past 3 months (%) 30.0 22.6 34.4 28.6
Values shown for age variables are mean ± SD (range). Chi-square tests were used except for age variables, which were
examined using t-tests.
aNo signiﬁcant differences (p ≤ 0.05) between above groups by low and high fuels category. bOne participant had missing
information (n = 99). questionnaires, diaries, and daily urine sam-
ples and for the 63 participants with breath
sample data. In both groups, the average age
of respondents was approximately 31 years.
In both groups, respondents were predomi-
nantly white, military, and married, had chil-
dren, had attended some college, and had
annual household incomes of at least
$30,000, and most had no history of irregu-
lar menses or dysmenorrhea within 3 months
of the interview. Characteristics of the low-
versus high-exposure groups for C6–C16 and
for BTEX also were similar, and none of
these differences was statistically signiﬁcant.
Internal dose (breath) analysis. Tables 2
and 3 present individual C6–C16 and BTEX
HCs measured in postshift breath samples,
grouped by low (n = 32) versus high (n = 31)
analysis categories. Mean internal doses for
the high BTEX category were highest for
m,p-xylene (37.3 ppb), followed by benzene
(13.0 ppb), o-xylene (11.3 ppb), toluene (9.0
ppb), and ethylbenzene (3.0 ppb). When we
combined the high- and low-BTEX groups,
toluene was the most frequently detected
among the BTEX analytes, present in 71.4%
of all breath samples, with levels ranging
from below detection to 52.0 ppb. Xylenes
were detectable in roughly one-half of all
samples with m,p-xylene (57.1%) and
o-xylene (47.6%), followed in frequency by
benzene (30.2%) and ethylbenzene (22.2%).
Within the high C6–C16 category (n =
22), the mean internal dosage for decane
(159.1 ppb) was highest, followed by hexane
(51.4 ppb), heptane (35.4 ppb), undecane
(28.7 ppb), nonane (4.5 ppb), and octane
(0.6 ppb). Both decane and hexane were vir-
tually ubiquitous, and heptane was present
in most (63.6%) of the samples in the high
and low C6–C16 groups. Many samples also
contained octane, nonane, and undecane in
both high and low C6–C16 groups. This
convenience sample of 22 contained a higher
proportion of women reportedly in exposed
jobs (40%) than did the larger group of 63
(23%) and therefore was most representative
of a more highly exposed setting.
Endocrine assessment. Mean levels of the
four study endocrine end points for all the
100 participants who provided both diaries
and concurrent daily hormonal data during
the study menstrual cycle were similar above
and below the median for each of the
reported exposure variables. Furthermore,
we found no signiﬁcant (p ≤ 0.05) difference
in endocrine levels between self-reported
exposed versus nonexposed participants
when examined bivariately or in multivari-
able regression models including potential
confounders and covariates.
Figure 1 illustrates mean endocrine levels
across the menstrual cycle for participants’
high and low aliphatic HC (C6–C16) levels
and highlights the four study end points.
Table 4 presents mean urinary levels of these
four end points by low and high breath lev-
els of C6–C16 and BTEX, the primary expo-
sure variables. Mean preovulatory LH levels
were signiﬁcantly lower in participants with
high breath C6–C16 (15.4 vs. 22.6 mIU
LH/mg creatinine; p = 0.01) and BTEX
(15.8 vs. 22.0 mIU LH/mg creatinine; p =
0.03) in the bivariate analysis. The difference
between the high- and low-BTEX groups
also approached significance in bivariate
analysis for midluteal Pd3G (8.5 vs. 12.0
µg/mg creatinine; p = 0.06).
We modeled each of the four endocrine
outcomes in separate multiple regressions
(Table 5). To aid in interpretation, we
obtained values reported for regression
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Table 2. Breath levels (ppb) of aromatic HCs by analyte and exposure group.
BTEX analyte Low (n = 32) High (n = 31) Total (n = 63)
Benzene (C6H6)
Mean ± SD (median) 0.5 ± 1.6 (ND) 13.0 ± 27.5 (ND) 6.6 ± 20.2 (ND)
Range ND–8.6 ND–97.5 ND–97.5
Percent of samples 18.8 41.9 30.2
Toluene (C6H5CH3)
Mean ± SD (median) 1.3 ± 2.2 (0.1) 9.0 ± 12.3 (5.1) 5.1 ± 9.5 (1.5)
Range ND–7.5 ND–52.0 ND–52.0
Percent of samples 50.0 93.5 71.4
Ethylbenzene (C6H5C2H5 )
Mean ± SD (median) 1.0 ± 0.5 (ND) 3.0 ± 6.9 (ND) 1.5 ± 5.0 (ND)
Range ND–2.7 ND–35.7 ND–35.7
Percent of samples 9.4 35.5 22.2
m,p-Xylene [C6H4(CH3)2]
Mean ± SD (median) 0.8 ± 1.2 (ND) 37.3 ± 85.6 (3.8) 18.7 ± 62.3 (0.8)
Range ND–4.4 ND–400.9 ND–400.9
Percent of samples 40.6 74.2 57.1
o-Xylene [C6H4(CH3)2]
Mean ± SD (median) 1.0 ± 2.0 (ND) 11.3 ± 15.0 (7.2) 6.1 ± 11.7 (ND)
Range ND–6.9 ND–67.3 ND–67.3
Percent of samples 28.1 67.7 47.6
Total BTEX [C6H6–C6H4(CH3)2]
Mean ± SD (median) 3.8 ± 3.8 (2.9) 73.5 ± 86.2 (32.4) 38.1 ± 69.6 (11.7)
Range ND–11.7 11.8–415.1 ND–415.1
Percent of samples 81.3 100.0 90.5
ND, nondetectable was assigned the value of zero for calculation of means and SDs.
Table 3. Breath levels (ppb) of aliphatic HCs by analyte and exposure group.
Aliphatic analyte Low (n = 11) High (n = 11) Total (n = 22)
Hexane (C6H14)
Mean ± SD (median) 17.6 ± 8.6 (19.6) 51.4 ± 62.9 (35.9) 34.5 ± 47.1 (25.9)
Range ND–28.5 11.7–238.7 ND–238.7
Percent of samples 90.9 100.0 95.4
Heptane (C7H16)
Mean ± SD (median) 3.7 ± 9.8 (0.3) 35.4 ± 75.3 (4.4) 19.5 ± 54.9 (0.6)
Range ND–33.0 ND–248.7 ND–248.7
Percent of samples 63.6 63.6 63.6
Octane (C8H18)
Mean ± SD (median) 0.2 ± 0.4 (ND) 0.6 ± 1.8 (ND) 0.4 ± 1.3 (ND)
Range ND–1.2 ND–6.0 ND–6.0
Percent of samples 18.2 27.3 22.7
Nonane (C9H20)
Mean ± SD (median) 5.3 ± 10.9 (ND) 4.5 ± 9.1 (ND) 4.9 ± 9.8 (ND)
Range ND–29.2 ND–27.0 ND–29.2
Percent of samples 36.4 45.4 40.9
Decane (C10H22)
Mean ± SD (median) 34.6 ± 23.5 (28.4) 159.1 ± 237.4 (14.8) 96.9 ± 176.6 (23.9)
Range 12.8–76.8 2.8–659.7 2.8–659.7
Percent of samples 100.0 100.0 100.0
Undecane (C11H24)
Mean ± SD (median) 8.8 ± 14.6 (ND) 28.7 ± 68.9 (ND) 18.7 ± 49.7 (ND)
Range ND–45.0 ND–226.7 ND–226.7
Percent of samples 36.4 36.4 36.4
Total C6H16–C11H24
Mean ± SD (median) 70.1 ± 31.3 (63.4) 279.6 ± 276.2 (170.8) 174.9 ± 219.8 (66.6)
Range 28.6–128.0 39.5–765.1 28.6–765.1
Percent of samples 100.0 100.0 100
ND, nondetectable was assigned the value of zero for calculation of means and SDs. coefﬁcients in Table 5 by applying the same
models with nontransformed outcomes.
High versus low exposure to C6–C16 HCs
was inversely related (β = –7.34; p = 0.007)
to preovulatory LH adjusted for age (β =
0.49; p = 0.05) and exposure to BTEX.
C6–C16 and BTEX categories were not sig-
nificantly associated with changes in mid-
luteal E13G, or with follicular or midluteal
Pd3G levels.
Illness and/or fever > 101°F was associ-
ated with elevated midluteal E13G (β = 8.93;
p = 0.01). Other potential covariates and con-
founders were not associated (p ≥ 0.05) with
any of the hormonal outcomes after adjust-
ment. When analyzed as continuous variables,
neither total BTEX nor toluene, a component
of BTEX, was signiﬁcantly (p ≤ 0.05) associ-
ated with any of the hormonal levels.
However, toluene approached signiﬁcance (β
= –0.19; p = 0.058) with preovulatory LH in
a model together with C6–C16 (β = –7.17; p =
0.01) and age (β = 0.51; p = 0.04).
Discussion
We selected four urinary endocrine end
points (preovulatory LH, midluteal E13G,
follicular Pd3G, and midluteal Pd3G) based
on heuristic evidence that they are jointly
predictive of the probability of conception
in women within a given ovulatory men-
strual cycle (Baird et al. 1999). We found
that preovulatory LH in urine was lower in
healthy, reproductive-age women who had
higher internal doses of aliphatic HCs in
exhaled breath. Although we performed
multiple statistical tests, the association
between LH and aliphatic HCs remained
significant (p ≤ 0.013) after we applied a
Bonferroni correction for the four separate
hormone models.
In an examination of ovulatory cycles,
Baird et al. (1999) reported that nonconcep-
tive versus conceptive cycles had urinary pre-
ovulatory mean LH levels of 13.4 versus 15.2
mIU/mg creatinine, respectively. Our high
versus low aliphatic HC exposure groups had
urinary LH levels of 15.4 versus 22.6
mIU/mg creatinine, respectively. Although
we used the same assay to measure LH in
both of these studies, they are not directly
comparable quantitatively. The urine samples
from the present study contained 7% glycerol
to preserve LH immunoreactivity (Kesner et
al., 1995), whereas those used by Baird et al.
(1999) had been stored frozen for many years
without preservative. So although qualitative
comparisons are valid within Baird et al.’s
study, the LH values in that study are
expected to be lower than those in the present
study. Because these preovulatory LH levels
cannot be directly compared, whether the
lower levels seen among women in the high
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Figure 1. Crude concentrations of urinary LH, E13G, and Pd3G (creatinine-adjusted) during the menstrual
cycles of female USAF personnel with low (n = 31) and high (n = 32) total aliphatic HC exposure. Cr, creati-
nine. Values (means ± SE) are plotted relative to menses onset and the estimated day of ovulation (blue
line) as defined in “Materials and Methods.” Shaded regions highlight the four endocrine end points
examined. (Although follicular-phase Pd3G represents a series of contiguous days, the shaded region is
graphically split across segments). The low and high aliphatic groups include women with breath
aliphatic HC levels below and above the median for the AUC. Regression analysis revealed that preovula-
tory LH levels were lower (p = 0.007) among women with high aliphatic HC levels.
Table 4. Unadjusted endocrine outcomes: means
by breath aliphatic and BTEX HC exposure groups.
Endocrine outcome/ Endocrine level
exposure Mean ± SD Range
Preovulatory LH (mIU/mg Cr)
Aliphatics*
Low 22.6 ± 12.0 4.8–55.3
High 15.4 ± 8.2 3.0–39.0
BTEX**
Low 22.0 ± 12.2 4.3–55.3
High 15.8 ± 8.2 3.0–38.7
Follicular Pd3G (µg/mg Cr)
Aliphatics
Low 1.2 ± 0.7 0.01–2.7
High 1.2 ± 0.8 0.04–3.6
BTEX
Low 1.2 ± 0.7 0.3–3.6
High 1.1 ± 0.8 0.01–3.5
Midluteal Pd3G (µg/mg Cr)
Aliphatics
Low 10.0 ± 6.3 0.1–24.5
High 10.5 ± 7.4 2.2–37.9
BTEX#
Low 12.0 ± 8.1 0.3–37.9
High 8.5 ± 4.9 0.1–18.8
Midluteal E13G (ng/mg Cr)
Aliphatics
Low 27.2 ± 13.6 9.5–82.5
High 24.9 ± 13.1 2.1–58.8
BTEX
Low 27.3 ± 13.4 11.7–82.5
High 24.8 ± 13.3 2.1–58.8
Cr, creatinine. 
*Signiﬁcance (p = 0.01) between high and low categories
in unadjusted, bivariate analysis (t-test). **Significance
(p = 0.03) between high and low categories in unad-
justed, bivariate analysis (t-test). #Signiﬁcance (p = 0.06)
between high and low categories in unadjusted bivariate
analysis (t-test).aliphatic HC exposure group were sufﬁciently
low to affect conception is unclear. We did
not design the present study to detect concep-
tions, and it did not have the power to do so.
Studies designed to detect potential effects of
aliphatic HC exposure on the ability to con-
ceive and maintain pregnancies are indicated.
The mechanism by which aliphatic HCs
could lower LH levels is unknown. LH levels
could potentially be lowered by effects on the
pituitary gland, hypothalamus, or extrahypo-
thalamic central nervous system inputs.
Evidence derived from animal experiments
demonstrates that exposure to high doses of
aromatic HCs alters levels of hypothalamic
neurotransmitters, including noradrenaline
and dopamine (Andersson et al. 1980, 1981),
which are involved in regulating pituitary
hormone secretions. Andersson et al. (1980)
reported that toluene-exposed mice had
increased hypothalamic noradrenaline and
dopamine with a concomitant nonsigniﬁcant
(p > 0.05) decrease in LH secretion.
Few published studies have examined the
effects of exposure to low levels of fuels and
mixed solvents on the human neuroen-
docrine system, although neurologic
(ATSDR 1993; Grasso 1988; Knave et al.
1979; Langman 1994; Smith et al. 1997b)
and sensory-neural (Kaufman 1998; Morata
et al. 1997) effects of solvents have been doc-
umented at low and high analyte levels.
Subclinical and clinical central nervous sys-
tem effects have been reported to manifest at
ambient levels as low as 0.07–5 ppm
(Langman 1994). The only human studies of
the effects of HCs on gonadotropins, to our
knowledge, were of toluene exposure
(Luderer et al. 1999; Svensson et al. 1992a,
1992b). In the present study, breath toluene
approached (p = 0.058), but did not reach, a
significant inverse relationship with LH.
However, significantly lowered LH levels
have been reported among toluene-exposed
male printers (Svensson et al. 1992b). This
effect was reversed after a 4-week nonwork-
ing period, after which blood toluene levels
dropped and follicle-stimulating hormone
and LH rebounded 37.5% and 29.9%,
respectively (Svensson et al. 1992a). Results
from these studies, mostly of men, are salient
because LH controls the secretion of sex hor-
mones in both genders. In women, LH is
essential for ovulation and luteinization.
Although the primary exposure variables
for these analyses were breath levels of the
aliphatic and BTEX HCs in fuels and sol-
vents, a secondary source of exposure infor-
mation was self-report in participants’ daily
diaries and baseline questionnaires. Reported
hours of exposure were consistent with job
categories because women in fuel handling,
flight line, and maintenance jobs reported
more hours of exposure than women in
“nonexposed” jobs. However, reported hours
of exposure were similar for women with low
and high levels of aliphatic and BTEX HCs
in exhaled breath. One explanation is that,
although hours of exposure were similar
across exposed and nonexposed job cate-
gories, the intensity of exposure was greater
in exposed job categories. Accordingly, a
higher percentage of women in exposed job
categories were in the high breath aliphatic
and BTEX groups. The discrepancy between
reported and breath data could also be due,
in part, to poor recall or directional recall
bias. Underreporting of hours of exposure for
women in contact with fuels at work could
have resulted if workplace exposures were too
low for participants to perceive, or if they
became desensitized to the odor. Conversely,
low levels of exposure may have been com-
mon and perceptible, with resultant over- or
underestimation of self-reported hours of
exposure among those with higher fuel and
solvent contact. Mean breath aliphatic and
aromatic levels among self-reported nonex-
posed participants in the present study were
generally higher than for USAF workers with
solvent and fuel contact in other studies
(Lemasters et al. 1997; Pleil et al. 2000) and
therefore may have been detectable by some
participants. Median aliphatic HC levels
among the women (n = 22) who provided
breath samples and reported low fuel expo-
sure were similar to those reported in the gen-
eral U.S. population (TEAM study) (Wallace
et al. 1996), except for decane, which was
higher in our subgroup. Differences in
reported exposure and breath analyte levels
could also be attributed to using a single
breath sample to represent typical exposure
levels. This discrepancy could also be due to
interindividual differences in analyte reten-
tion times; however, retention times are
unlikely to differ systematically between the
breath exposure groups.
Overrepresentation of women with con-
cerns about their reproductive health in the
ﬁnal study population could have resulted in
bias due to self-selection and nonresponse. We
noted no apparent evidence of such bias how-
ever. We observed no signiﬁcant differences
between women in exposed versus nonex-
posed jobs regarding the proportion of women
who reported preexisting reproductive symp-
toms (dysmenorrhea, irregular cycles, infertil-
ity), although only large differences in these
nonhormone variables would be detectable
statistically, given our small group sizes.
Further, only one of the women reported hav-
ing a reproductive condition (ﬁbroids), and
none reported endometriosis or polycystic
ovarian syndrome. Self-reported conditions
should be interpreted with caution because
women are sometimes unaware of early, often
subclinical, pregnancy losses and undiagnosed
reproductive abnormalities. Prevalences of
severe dysmenorrhea (31%) and abnormal
(< 24 or > 35 days) cycle lengths (12%) were
previously reported to be similar between the
larger study group of 170 participants and the
general population (Gordley et al. 2000). The
subset of 63 of the 170 participants had com-
parable prevalences of severe dysmenorrhea
(37%) and abnormal cycle lengths (13%).
Gender differences in the effects of these
HCs on the neuroendocrine system may be
anticipated based on differences in the neu-
roendocrine axes and reproductive organs, as
well as differences in metabolism, storage,
and excretion of lipophilic HCs (Brown
1998). The focus of the present investigation
was on hormones that affect female fertility.
Future studies should examine both men and
women. Solvent exposure has been reported
to decrease sperm motility (Lemasters et al.
1999b) and may increase the rate of sperm
anomalies in men.
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Table 5. Results of multiple regression of each of the endocrine outcomes.
Covariatesa 
Endocrine outcomes Modelb Aliphatics BTEX Age Race group Illness/fever Alcohol Job strain
Preovulatory LH (n = 58) F = 5.28 β = –7.34 (2.60)c β = –4.61 (2.59) β = 0.49 (0.24) — — — —
p = 0.003 p = 0.007 p = 0.10 p = 0.05
Follicular Pd3G (n = 62) F = 0.46 β = 0.04 (0.20) β = –0.10 (0.20) — — — — —
p = 0.64 p = 0.89 p = 0.34
Midluteal Pd3G (n = 58) F = 1.68 β = 1.04 (1.79) β = –3.59 (1.79) — — — — —
p = 0.20 p = 0.51 p = 0.08
Midluteal E13G (n = 58) F = 2.79 β = –2.79 (3.18) β = –2.73 (3.38) — — β = 8.93 (3.37) — —
p = 0.05 p = 0.34 p = 0.32 p = 0.01
aAliphatics and BTEX were retained in each ﬁnal model; other covariates in the full models (age, maximum job strain, illness/fever > 101°F, alcoholic beverages, race group) were not
retained in any of the ﬁnal models because p > 0.05 (—); p-values were generated from transformed models, and β-values from untransformed models. bAdjusted model r2: LH = 0.18,
E13G = 0.09; follicular Pd3G = 0.00; midluteal Pd3G = 0.02. cSEs of the β-values are shown in parentheses.Conclusions
Internal dose of compounds in fuel is associ-
ated with reduced LH levels prior to ovula-
tion in women of reproductive age. Several
other caveats must be considered regarding
interpretation of these results. The aliphatic
and aromatic compounds we chose to repre-
sent exposure likely are also markers of expo-
sure to the complex mixture of other
compounds found in fuels, including addi-
tives and by-products of combustion. The
design was cross-sectional, and exposures or
endocrine measurements assessed during the
study cycle may or may not represent past
exposure and/or endocrine levels. However, if
HC exposures chronically alter LH levels, this
effect could impact LH-dependent processes
and thereby compromise reproduction.
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